Pre-Anaesthetic Evaluation (Preoperative Assessment Note)
Patient Identification:
Full Name: Ms. Amelia Sharma
Hospital Number: 7890123
Date of Birth: 15/03/1978
Gender: Female
Procedure Details:
Planned Procedure: Laparoscopic Cholecystectomy
Expected Date: 1 November 2024
Hospital/Clinic Location: General Hospital Surgical Ward
Responsible Surgeon/Proceduralist: Dr. Eleanor Vance (General Surgeon)
Medical History:
Chronic Illnesses: Hypertension (controlled with medication), Type 2 Diabetes Mellitus (managed with oral hypoglycaemics), history of seasonal asthma (well-controlled, last exacerbation 3 years ago).
Previous Surgical History: Appendectomy at age 12, wisdom teeth extraction at age 25.
Known Diagnoses: Essential Hypertension, Type 2 DM, well-controlled asthma.
Comorbidities: No acute comorbidities affecting anesthetic risk at present.
Medication History:
Current Medications: Ramipril 5mg daily, Metformin 1000mg twice daily, Salbutamol inhaler as needed (rarely used).
Supplements: Multivitamin daily.
Recent Changes: No recent changes in treatment.
Allergies:
Drug Allergies: Penicillin (rash, itching).
Food Allergies: None.
Latex Allergies: None.
Physical Examination:
General Clinical Assessment: Well-nourished, alert, and oriented female.
Weight: 70 kg
Height: 165 cm
Vital Signs: BP 130/85 mmHg, HR 72 bpm (regular), RR 16 breaths/min, SpO2 98% on room air.
Cardiovascular Exam: S1 S2 heard, no murmurs, gallops, or rubs. Peripheral pulses present and equal.
Respiratory Exam: Clear to auscultation bilaterally, no wheezes or crackles. Good air entry.
Airway Assessment:
Mallampati Score: Class II
Mouth Opening: Adequate (3 fingerbreadths)
Thyromental Distance: >6 cm
Neck Movement: Full range of motion
Loose/Missing Teeth or Dentures: No loose teeth, no dentures.
Other Airway Predictors: None identified.
Laboratory and Diagnostic Results:
Hb: 13.5 g/dL (normal)
Creatinine: 70 µmol/L (normal)
Glucose: 6.8 mmol/L (controlled)
ECG: Normal Sinus Rhythm, no ischaemic changes or arrhythmias.
Risk Stratification:
ASA Physical Status Classification: ASA II
Identified Risk Factors: Controlled hypertension and type 2 diabetes mellitus. No other significant risk factors.
Anesthetic Plan:
Proposed Anesthetic Technique: General Anaesthesia with LMA insertion.
Induction Strategy: Propofol induction, Fentanyl for analgesia, Rocuronium for muscle relaxation if required for LMA insertion.
Maintenance Strategy: Sevoflurane in air/oxygen mixture.
Monitoring Plans: Standard ASA monitoring (ECG, NIBP, SpO2, EtCO2).
Postoperative Care Needs: Standard post-operative recovery, routine pain management with paracetamol and ibuprofen, antiemetics as per protocol. Discharge to ward.
Consent:
Informed consent discussion for anaesthesia was conducted. Patient understands the risks (e.g., nausea, vomiting, sore throat, dental damage, awareness, allergic reaction) and benefits (pain relief, loss of consciousness). Alternatives were discussed (regional anaesthesia not suitable for this procedure). Patient had ample opportunity to ask questions and expressed understanding and agreement.
Special Considerations:
NPO Compliance: Patient is compliant with NPO guidelines (6 hours for solids, 2 hours for clear fluids).
Planned Surgical Position: Supine.
Blood Availability: Group and Save requested, no cross-match indicated.
Cultural Needs: None specified.
Interpreter Involvement: Not required.
Multidisciplinary Referrals: None indicated for pre-operative optimisation.
Clinician Signature:
Dr. Marcus Thorne, Anaesthetist, 1 November 2024
Pre-Anaesthetic Evaluation (Preoperative Assessment Note)
Patient Identification:
[Document patient’s full name, hospital number, date of birth or South African ID number if provided, and gender] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Procedure Details:
[Include the planned surgical or procedural intervention, expected date, hospital/clinic location, and the name or discipline of the responsible surgeon/proceduralist] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Medical History:
[Summarise relevant chronic illnesses (e.g. HIV, TB, hypertension, diabetes), previous surgical history, known diagnoses, and comorbidities affecting anesthetic risk] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Medication History:
[List current medications, including ARVs, chronic disease medication, psychiatric medication, supplements or traditional medicines, and any recent changes in treatment] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Allergies:
[Note any documented drug, food or latex allergies, with details about reaction type and severity where known] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Physical Examination:
[Include general clinical assessment findings such as weight, height (if relevant), vital signs, cardiovascular and respiratory exam, and any findings influencing anesthetic safety] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Airway Assessment:
[Document findings such as Mallampati score, mouth opening, thyromental distance, neck movement, presence of loose/missing teeth or dentures, and any other airway predictors] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Laboratory and Diagnostic Results:
[Include relevant blood tests (e.g. Hb, creatinine, glucose, CD4 count if relevant), chest X-ray, ECG, or other investigations used to guide anesthetic risk] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Risk Stratification:
[Record ASA physical status classification and any identified risk factors including poor nutritional status, chronic infection, limited functional capacity, or social vulnerabilities] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Anesthetic Plan:
[Outline proposed anesthetic technique (e.g. general, spinal, local with sedation), induction and maintenance strategy, monitoring plans, and postoperative care needs (e.g. pain management, high-care admission)] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Consent:
[Record details of the informed consent discussion for anesthesia, including discussion of risks, benefits, alternatives (if applicable), and whether the patient had an opportunity to ask questions] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Special Considerations:
[Mention any key issues such as NPO compliance, planned surgical position, blood availability, cultural needs, interpreter involvement, or multidisciplinary referrals (e.g. to medicine, cardiology, social work)] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Clinician Signature:
[Name of evaluating clinician, designation (e.g. medical officer, anesthetist), and date/time of assessment] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
(Never come up with your own patient details, assessment, plan, interventions, evaluation, and plan for continuing care. Use only the transcript, contextual notes, or clinical note as a reference for the information included in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes, or clinical note, you must not state that the information has not been explicitly mentioned in your output. Leave the relevant placeholder or section blank if it is not explicitly mentioned. Use as many full sentences as needed to capture all the relevant information from the transcript.)